COMBIGAN (Allergan, Inc.)


Welcome to the PulseAid listing for the COMBIGAN drug offered from Allergan, Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: brimonidine tartrate, timolol maleate
SUBSTANCE NAME: BRIMONIDINE TARTRATE; TIMOLOL MALEATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-11-14
END MARKETING DATE: 0000-00-00


COMBIGAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCOMBIGAN from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2; 5(mg/mL; mg/mL)
START MARKETING DATE: 2007-11-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-9211_923b2701-ec40-40c4-85cb-f6642b687d12
PRODUCT NDC: 0023-9211
APPLICATION NUMBER: NDA021398

Other BRIMONIDINE TARTRATE; TIMOLOL MALEATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.COMBIGAN
Physicians Total Care, Inc.COMBIGAN